Cargando…
Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer
As the incidence of cancer increases worldwide there is an unmet need to understand cancer evolution to improve patient outcomes. Our growing knowledge of cancer cells’ clonal expansion, heterogeneity, adaptation, and relationships within the tumor immune compartment and with the tumor microenvironm...
Autores principales: | Velazquez, Ana I., McCoach, Caroline E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330358/ https://www.ncbi.nlm.nih.gov/pubmed/32642202 http://dx.doi.org/10.21037/jtd.2019.08.31 |
Ejemplares similares
-
Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer
por: Gini, Beatrice, et al.
Publicado: (2020) -
Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors
por: Chen, Justin A., et al.
Publicado: (2020) -
EGFR targeted therapy resistance: current status, challenges, and future outlook
por: Bivona, Trever G.
Publicado: (2020) -
Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer
por: Bulbul, Ajaz, et al.
Publicado: (2020) -
Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)